Fluoptics Overview

  • Founded
  • 2009
Founded
  • Status
  • Private
  • Employees
  • 23
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $640K
Latest Deal Amount
  • Investors
  • 6

Fluoptics General Information

Description

Developer of a fluorescence imaging technology designed to optically guide cancer surgery. The company's technology is a real-time near-infrared imager that combines autofluorescence and fluorescence perfusion imaging to provide the surgeon with a perfect understanding of the location and perfusion of the parathyroid glands, enabling surgeons to secure and improve the effectiveness of the interventions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Surgical Devices
Primary Office
  • Min atec-BHT - Build 52
  • 7, parvis Lo uis Néel, C S 20050
  • 38040 Grenoble
  • France
+33 04 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Fluoptics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 18-May-2017 $640K 00.000 000.00 Completed Generating Revenue
5. Later Stage VC 12-May-2016 00000 00.000 000.00 Completed Generating Revenue
4. Later Stage VC 28-Jun-2015 00000 00.000 000.00 Completed Generating Revenue
3. Early Stage VC (Series B) 24-Sep-2013 00.000 00.000 00.000 Completed Generating Revenue
2. Seed Round 04-May-2010 $1.01M $1.01M 00.000 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Fluoptics’s complete valuation and funding history, request access »

Fluoptics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 000,000 00.000000 00.00 00.00 00 00.00 0.000
Ordinary 000,000 00.000000 00.00 00.00 00 00.00 0.000
Ordinary 000,000 00.000000 00.00 00.00 00 00.00 0.000
Ordinary 1,666,600 $0.010915 $1.31 $1.31 1x $1.31 28.6%
P shares 1,250,300 $0.010915 $0.65 $0.65 1x $0.65 21.45%
To view Fluoptics’s complete cap table history, request access »

Fluoptics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a fluorescence imaging technology designed to optically guide cancer surgery. The company's technology is a
Diagnostic Equipment
Grenoble, France
23 As of 2020
00.000
00.00 0000-00-00
0000000000 0 00.000

000000 0

, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis n
0000000000 000000000
Stratford, CT
000000000 -

00000000

t aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse ci
00000000 0000000
Newton, MA
00 As of 0000
000.00
000000000 - 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Fluoptics Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Kubtec Medical Imaging Corporation Stratford, CT 000000000 -
00000000 Venture Capital-Backed Newton, MA 00 000.00 000000000 - 000.00
0000000 00000000 Formerly VC-backed Morrisville, NC 000 00000 00000000000 00000
0000000000 0000000 Venture Capital-Backed Chicago, IL 0 00.000 0000000000 0 00.000
000000000 00000000 Corporation Richmond, Canada 00 000.00 000000&0
You’re viewing 5 of 10 competitors. Get the full list »

Fluoptics Executive Team (5)

Name Title Board Seat Contact Info
Odile Allard Chief Executive Officer, Chairman & Co-Founder
Christophe Haond Director, Commercial & Business Development
Philippe Rizo Co-Founder & Technical Strategy Manager
Cécile Réal Co-Founder & Advisor, Strategy
You’re viewing 4 of 5 executive team members. Get the full list »

Fluoptics Board Members (2)

Name Representing Role Since
Jean Luc Butel Self Board Member & Strategic Advisor 000 0000
Nicolas Boulay Sofimac Innovation Board Member 000 0000
To view Fluoptics’s complete board members history, request access »

Fluoptics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Fluoptics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Sofimac Innovation Venture Capital Minority 000 0000 000000 0
CEA Investissement Corporate Venture Capital Minority 000 0000 000000 0
Grenoble Angels Angel Group Minority 000 0000 000000 0
Savoie Angels Angel Group Minority 000 0000 000000 0
Viaduc Other Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »